TR

Important Dates

Congress Date : September 25-27, 2025
Deadline for Abstract Submission : June 12, 2025
Announcement Date for Accepted Abstracts : July 11, 2025
Early Registration Deadline : July 25, 2025

INVITED SPEAKERS ( TO BE UPDATED)

Prof. Agnes Kittel, Hungary

Imaging Gene Transcription

Prof. Dr. Bülent Ahıshalı, Türkiye

Blood-brain barrier as an obstacle in the treatment of neurodegenerative diseases; Current considerations and novel approaches

Prof. Çiler Çelik Özenci, Türkiye

Enhanced Human Placenta Organoids with Immune and Vascular Components for In Vivo-Like Function, Disease Modeling, and Therapeutic Testing

Prof. Gamze Tanrıöver, Türkiye

The Role of Inhibitors in Glioblastoma Treatment: Alternative or Support to Chemotherapy?

Prof. Leyla Satı, Türkiye

Pushing the Boundaries of Developmental Biology: A Technological Tour de Force in Creating True Interspecies Hybrids with Both a Hybrid Genome and Hybrid Cytoplasm

Prof. Michelangelo Campanella, Italy
Prof. Nalan Liv, The Netherlands
Prof. Nebile Dağlıoğlu, Türkiye
Prof. Özgür Kurt, Türkiye
Prof. Pavel Hozák, Czechia

Imaging gene transcription

Prof. Ranan Gülhan Aktaş, USA
Prof. Raymond Birge, USA
Prof. Roberta di Pietro, Italy
Prof. Seda Vatansever, Türkiye

Exosomes: Tiny Packages, Transformative Potential Biogenesis and Their Role in Medicine

Assist. Prof. Dr. Serçin Karahüseyinoğlu, Türkiye
Prof. Tamas Horvath, USA
Prof. Tanıl Kocagöz, Türkiye
Prof. Toyoshi Fujimoto, Japan

Lipid Droplets and Nuclear Structures

Prof. Tuğba Bağcı Önder, Türkiye
Assoc. Prof. Bükem Tanören, Türkiye

Theranostics

Assoc. Prof. Gamze Güney Eskiler, Türkiye

Targeting the Cell Cycle with Lipid-Polymer Hybrid Nanoparticles: Molecular Perspectives in Triple Negative Breast Cancer

Assoc. Prof. Özgül Gök, Türkiye

Morphological Evaluation of Biomolecule-Conjugated Nanomedicine Platforms

Dr. Jitske Jansen, Germany

Human Kidney Organoids to Model Glomerular Disorders and Kidney Fibrosis

Dr. Roya Khosravi-Far, USA

Multiomics in Minutes: The Next Frontier of Non-Invasive Cancer Diagnostics

Dr. Stefan H. Fuss, Türkiye
Dr. Şevin Turcan, Germany

The Role of IDH Mutations in Brain Tumors